GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYY) » Definitions » PEG Ratio

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) PEG Ratio : 0.56 (As of Apr. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is China Shineway Pharmaceutical Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, China Shineway Pharmaceutical Group's PE Ratio without NRI is 6.77. China Shineway Pharmaceutical Group's 5-Year EBITDA growth rate is 12.00%. Therefore, China Shineway Pharmaceutical Group's PEG Ratio for today is 0.56.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for China Shineway Pharmaceutical Group's PEG Ratio or its related term are showing as below:

CSWYY' s PEG Ratio Range Over the Past 10 Years
Min: 0.46   Med: 0.95   Max: 24.75
Current: 0.56


During the past 13 years, China Shineway Pharmaceutical Group's highest PEG Ratio was 24.75. The lowest was 0.46. And the median was 0.95.


CSWYY's PEG Ratio is ranked better than
85.56% of 374 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs CSWYY: 0.56

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


China Shineway Pharmaceutical Group PEG Ratio Historical Data

The historical data trend for China Shineway Pharmaceutical Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group PEG Ratio Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.30 0.67 0.43

China Shineway Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 - 0.67 - 0.43

Competitive Comparison of China Shineway Pharmaceutical Group's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Shineway Pharmaceutical Group's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's PEG Ratio falls into.



China Shineway Pharmaceutical Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

China Shineway Pharmaceutical Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=6.7668336115748/12.00
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


China Shineway Pharmaceutical Group  (OTCPK:CSWYY) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


China Shineway Pharmaceutical Group PEG Ratio Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines